Belfast techbio raises £1.4m to tackle complex diseases
Drug Discovery World
FEBRUARY 16, 2024
The company, which is a spin-out from the Queen’s University Belfast, was established in 2021 to commercialise a drug discovery platform developed by researchers in the School of Biological Science at Queen’s. AMPLY is currently focused on two R&D programmes which will provide technical validation for its development platform.
Let's personalize your content